Filing Details

Accession Number:
0001232524-13-000015
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-06 20:35:54
Reporting Period:
2013-03-05
Filing Date:
2013-03-06
Accepted Time:
2013-03-06 20:35:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1193210 C Bruce Cozadd C/O Jazz Pharmaceuticals Plc
Connaught House, 1 Burlington Rd, Fl. 4
Dublin 4 L2
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2013-03-04 1,000 $60.00 577,161 No 4 S Direct
Ordinary Shares Acquisiton 2013-03-05 50,000 $0.00 627,161 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Nonstatutory Stock Option (right to buy) Acquisiton 2013-03-05 123,309 $0.00 123,309 $59.13
Ordinary Shares Incentive Stock Option (right to buy) Acquisiton 2013-03-05 1,691 $0.00 1,691 $59.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
123,309 2023-03-04 No 4 A Direct
1,691 2023-03-04 No 4 A Direct
Footnotes
  1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in four equal annual installments on the anniversary of the grant date, March 5, 2013.
  3. These two options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these two options vest over four years measured from the grant date, March 5, 2013, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.